Nacuda, Glory Belle D.
HRN: 05-41-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/08/2022
10/14/2022
IV
1vial
Q8H
S/p LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes